If the page does not redirect, click here
Drug proves safe, efficacious to treat children in Africa with malaria
Results of a multi-centre clinical trial in Africa, launched in 2008, to test the efficacy and tolerability of Artesunate-Mefloquine fixed-dose combination in children under 5 years of age with uncomplicated falciparum malaria showed that ASMQ FDC is as safe and efficacious as Artemether-Lumefantrine FDC -- Africa's most widely adopted treatment.